CVE-2020-27266

{"id": "CVE-2020-27266", "metrics": {"cvssMetricV2": [{"type": "Primary", "source": "nvd@nist.gov", "cvssData": {"version": "2.0", "baseScore": 3.3, "accessVector": "ADJACENT_NETWORK", "vectorString": "AV:A/AC:L/Au:N/C:P/I:N/A:N", "authentication": "NONE", "integrityImpact": "NONE", "accessComplexity": "LOW", "availabilityImpact": "NONE", "confidentialityImpact": "PARTIAL"}, "acInsufInfo": false, "impactScore": 2.9, "baseSeverity": "LOW", "obtainAllPrivilege": false, "exploitabilityScore": 6.5, "obtainUserPrivilege": false, "obtainOtherPrivilege": false, "userInteractionRequired": false}], "cvssMetricV31": [{"type": "Primary", "source": "nvd@nist.gov", "cvssData": {"scope": "UNCHANGED", "version": "3.1", "baseScore": 6.5, "attackVector": "ADJACENT_NETWORK", "baseSeverity": "MEDIUM", "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N", "integrityImpact": "NONE", "userInteraction": "NONE", "attackComplexity": "LOW", "availabilityImpact": "NONE", "privilegesRequired": "NONE", "confidentialityImpact": "HIGH"}, "impactScore": 3.6, "exploitabilityScore": 2.8}]}, "published": "2021-01-19T22:15:12.380", "references": [{"url": "https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01", "tags": ["Third Party Advisory", "US Government Resource"], "source": "ics-cert@hq.dhs.gov"}], "vulnStatus": "Analyzed", "weaknesses": [{"type": "Primary", "source": "nvd@nist.gov", "description": [{"lang": "en", "value": "CWE-287"}]}, {"type": "Secondary", "source": "ics-cert@hq.dhs.gov", "description": [{"lang": "en", "value": "CWE-603"}]}], "descriptions": [{"lang": "en", "value": "In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass user authentication checks via Bluetooth Low Energy."}, {"lang": "es", "value": "En SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i y AnyDana-A, una vulnerabilidad de control del lado del cliente en la bomba de insulina y sus aplicaciones m\u00f3viles AnyDana-i y AnyDana-A, permite a atacantes f\u00edsicamente pr\u00f3ximos omitir las comprobaciones de autenticaci\u00f3n del usuario por medio de Bluetooth Low Energy"}], "lastModified": "2021-10-19T12:18:13.690", "configurations": [{"nodes": [{"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:o:sooil:anydana-a_firmware:*:*:*:*:*:*:*:*", "vulnerable": true, "matchCriteriaId": "808DBA89-C2C2-4C03-814D-DB0B4DFF8B22", "versionEndExcluding": "3.0"}], "operator": "OR"}, {"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:h:sooil:anydana-a:-:*:*:*:*:*:*:*", "vulnerable": false, "matchCriteriaId": "2624582E-762F-4CDB-B974-1BC971F1544D"}], "operator": "OR"}], "operator": "AND"}, {"nodes": [{"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:o:sooil:anydana-i_firmware:*:*:*:*:*:*:*:*", "vulnerable": true, "matchCriteriaId": "98E25B7D-C1ED-4144-8411-171C7B6426E4", "versionEndExcluding": "3.0"}], "operator": "OR"}, {"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:h:sooil:anydana-i:-:*:*:*:*:*:*:*", "vulnerable": false, "matchCriteriaId": "E25CB863-07D9-4E90-8022-6C2B4C52EDFC"}], "operator": "OR"}], "operator": "AND"}, {"nodes": [{"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:o:sooil:diabecare_rs_firmware:*:*:*:*:*:*:*:*", "vulnerable": true, "matchCriteriaId": "C5C154F1-7F29-4EC0-9971-76A02C6DA8BC", "versionEndExcluding": "3.0"}], "operator": "OR"}, {"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:h:sooil:diabecare_rs:-:*:*:*:*:*:*:*", "vulnerable": false, "matchCriteriaId": "8628A530-AF34-453E-968A-40DD5B8EE456"}], "operator": "OR"}], "operator": "AND"}], "sourceIdentifier": "ics-cert@hq.dhs.gov"}